Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors

Michael Chuong; Kathryn Mittauer; Martin Tom; Noah Kalman; James McCulloch; Diane Alvarez; Paul Kaywin; Antonio Ucar; Federico Albrecht; Fernando De Zarraga; Santiago Aparo; Guilherme Rabinowits; Muni Rubens; Alonso Gutierrez; Rupesh Kotecha; Carolina Rojas

Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors

Michael Chuong
, Kathryn Mittauer
, Martin Tom
, Noah Kalman
, James McCulloch
, Diane Alvarez
, Paul Kaywin
, Antonio Ucar
, Federico Albrecht
, Fernando De Zarraga
, Santiago Aparo
, Guilherme Rabinowits
, Muni Rubens
, Alonso Gutierrez
, Rupesh Kotecha
, Carolina Rojas

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - May 12 2023

Cite this

@conference{f31828bca79342e7a889fe5713b3a19f,

title = "Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors",

author = "Michael Chuong and Kathryn Mittauer and Martin Tom and Noah Kalman and James McCulloch and Diane Alvarez and Paul Kaywin and Antonio Ucar and Federico Albrecht and \{De Zarraga\}, Fernando and Santiago Aparo and Guilherme Rabinowits and Muni Rubens and Alonso Gutierrez and Rupesh Kotecha and Carolina Rojas",

year = "2023",

month = may,

day = "12",

language = "American English",

}

TY - CONF

T1 - Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors

AU - Chuong, Michael

AU - Mittauer, Kathryn

AU - Tom, Martin

AU - Kalman, Noah

AU - McCulloch, James

AU - Alvarez, Diane

AU - Kaywin, Paul

AU - Ucar, Antonio

AU - Albrecht, Federico

AU - De Zarraga, Fernando

AU - Aparo, Santiago

AU - Rabinowits, Guilherme

AU - Rubens, Muni

AU - Gutierrez, Alonso

AU - Kotecha, Rupesh

AU - Rojas, Carolina

PY - 2023/5/12

Y1 - 2023/5/12

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4638

M3 - Presentation

ER -

Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors

Other files and links

Cite this